Article in Seminars in Cancer Biology · April 2008 doi: 10. 1016/j semcancer

Acknowledgments

The authors recognize the editorial contributions of Cheryl Schaeberle, Laura Vandenberg and Michael Askenase.

This research work has been supported in part by the US National Institutes of Health (NIEHS), the Susan G. Komen

Foundation, the Department of Defense, Philip Morris International and Aid for Cancer Research

References

1. Anderson ARA, Weaver AM, Cummings PT, Quaranta V. Tumor morphology and phenotypic

evolution driven by selective pressure from the microenvironment. Cell 2006:905–15. [PubMed:

17129778]

2. Varmus H. The new era in cancer research. Science 2006:1162–5. [PubMed: 16728627]

3. Alberts, B.; Johnson, A.; Lewis, J.; Raff, M.; Roberts, K.; Walter, P. Molecular Biology of the Cell.

New York, NY: Garland Publishing Inc.; 2001.

4. Soto AM, Sonnenschein C. Regulation of cell proliferation: the negative control perspective. Ann NY

Acad Sci 1991:412–8. [PubMed: 2069318]

5. Sonnenschein, C.; Soto, AM. The Society of Cells: Cancer and Control of Cell Proliferation. New

York: Springer Verlag; 1999.

6. Ribbert H. Zur Entstehung der Geschwuelste. Duetsche Medizinische Wochenzeitschrift 1896:471–

4.

7. Triolo VA. Nineteenth century foundations of cancer research origins of experimental research. Cancer

Res 1964:4–27. [PubMed: 14106160]

8. Potter JD. Morphostats: a missing concept in cancer biology. Cancer Epidem Biomar 2001:167–70.

9. Vogelstein B, Kinzler KW. Cancer genes and the pathways they control. Nature Medicine 2004:789–

99.

10. Radisky DC, Bissell MJ. Matrix metalloproteinase-induced genomic instability. Curr Opin Genet

Dev 2006:45–50. [PubMed: 16377172]

11. Laconi E. The evolving concept of tumor microenvironments. BioEssays 2007:738–44. [PubMed:

17621638]

12. Lakatos, I. The methodology of scientific research programmes. New York: Cambridge University

Press; 1978.

13. Luria, SE. 36 Lectures in Biology. Cambridge: MIT Press; 1975.

14. Soto AM, Sonnenschein C. Emergentism by default: A view from the bench. New perspectives on

reduction and emergence in physics, biology and psychology. Synthese 2006:361–76.

15. Soto AM, Sonnenschein C. Emergentism as a default: cancer as a problem of tissue organization. J

Biosci 2005:103–18. [PubMed: 15824446]

16. Soto AM, Sonnenschein C. The somatic mutation theory of cancer: growing problems with the

paradigm? BioEssays 2004:1097–107. [PubMed: 15382143]

Sonnenschein and Soto

Page 8

Semin Cancer Biol. Author manuscript; available in PMC 2009 October 1.

NIH-PA Author Manuscript

NIH-PA Author Manuscript

NIH-PA Author Manuscript

---

17. Sonnenschein, C.; Soto, AM. The Society of Cells: Cancer and Control of Cell Proliferation. New

York: Springer Verlag; 1999.

18. Harris H. Tumor suppression: putting on the breaks. Nature 2004:201. [PubMed: 14724616]

19. Moreno-Cuevas JE, Sirbasku DA. Estrogen mitogenic action. I. Demonstration of estrogen-dependent

MTW9/PL2 carcinogen-induced mammary tumor cell growth in serum-supplemented culture and

technical implications. In Vitro Cell Dev Biol 2000:410–27.

20. Moreno-Cuevas JE, Sirbasku DA. Estrogen mitogenic action. III. Is phenol red a “red herring”? In

Vitro Cell Dev Biol 2000:447–64.

21. Soto AM, Sonnenschein C. Cell proliferation of estrogen-sensitive cells: the case for negative control.

Endocr Rev 1987:44–52. [PubMed: 3549277]

22. Yusuf I, Fruman DA. Regulation of quiescence in lymphocytes. Trends in Immunology 2003:380–

6. [PubMed: 12860529]

23. Passegué E, Wagers AJ. Regulating quiescence: new insights into hematopoietic stem cell biology.

Developmental Cell 2006:415–7. [PubMed: 16580989]

24. Gottlieb B, Beitel LK, Trifiro M. Will knowledge of human genome variation result in changing

cancer paradigms? BioEssays 2007:678–85. [PubMed: 17563087]

25. Crowe SE. Helicobacter infection, chronic inflammation, and the development of malignancy. Current

Opinions in Gastroenterology 2005:32–8.

26. Utzinger J, Xiao SH, Tanner M, Keiser J. Artemisinins for schistosomiasis and beyond. Current

Opinion in Investigational Drugs 2007:105–16. [PubMed: 17328226]

27. Woodman CBJ, Collins SI, Young LS. The natural history of cervical HPV infection: unresolved

issues. Nat Rev Cancer 2007:11–22. [PubMed: 17186016]

28. Foulds, L. Neoplastic Development. New York, NY: Academic Press; 1969.

29. Farber E. Chemical carcinogenesis: a current biological perspective. Carcinogenesis 1984:1–5.

[PubMed: 6690079]

30. Mechler BM, Strand D, Kalmes A, Merz R, Schmidt M, Torok I. Drosophila as a model system for

molecular analysis of tumorogenesis. Environ Health Perspect 1991:63–71. [PubMed: 1773803]

31. Demant P. Genetic resolution of scusceptibility to cancer-new perstectives. Seminars in Cancer

Biology 1992:159–66. [PubMed: 1511158]

32. Aranda-Anzaldo A. Cancer development and progression:a non-adaptive process driven by genetic

drift. Acta Biotheoretica 2001:89–108. [PubMed: 11450810]

33. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000:57–70. [PubMed: 10647931]

34. Reitmair AH, Cai JC, Bjerknes M, Redston M, Cheng H, Pind MTL, Hay K, Mitri A, Bapat BV, Mak

TW, Gallinger S. MSH2 deficiency contributes to accelerated APC-mediated intestinal

tumorigenesis. Cancer Res 1996:2922–6. [PubMed: 8674041]

35. Kinzler KW, Vogelstein B. Lessons from hereditary colorectal cancer. Cell 1996:159–70. [PubMed:

8861899]

36. Feinberg AP, Ohlsson R, Henikoff S. The epigenetic progenitor origin of human cancer. Nat Rev

Genet 2005:21–33.

37. Jones PA, Baylin SB. The epigenomics of cancer. Cell 2007:683–92. [PubMed: 17320506]

38. Sonnenschein, C.; Soto, AM. The Society of Cells: Cancer and Control of Cell Proliferation. New

York: Springer Verlag; 1999.

39. Bissell MJ, Kenny PA, Radisky DC. Microenvironmental regulators of tissue structure and function

also regulate tumor induction and progression: the role of extracellular matrix and its degrading

enzymes. Cold Spring Harbor Symposia 2005:343–56.

40. Rubin H. What keeps cells in tissues behaving normally in the face of myriad mutations? BioEssays

2006:515–24. [PubMed: 16615084]

41. Illmensee K, Mintz B. Totipotency and normal differentiation of single teratocarcinoma cell cloned

by injection into blastocysts. Proc Nat Acad Sci USA 1976:549–53. [PubMed: 1061157]

42. Li L, Connelly MC, Wetmore C, Curran T, Morgan JI. Mouse embryos cloned from brain tumors.

Cancer Res 2003:2733–6. [PubMed: 12782575]

43. Hochedlinger K, Blelloch R, Brennan C, Yamada Y, Kim M, Chin L, Jaenisch R. Reprogramming

of a melanoma genome by nuclear transplantation. Genes Dev 2004:1875–85. [PubMed: 15289459]

Sonnenschein and Soto

Page 9